Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–70.

Article  PubMed  Google Scholar 

Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. The Lancet Diabetes & Endocrinology. 2017;5(6):423–30.

Article  Google Scholar 

Jafarvand E, Ataey A, Edalati S. Epidemiology and death trends due to diabetes in Iran. Intern Med Today. 2021;27(2):198–213.

Google Scholar 

Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The Burden of Mortality Attributable to Diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28(9):2130–5.

Article  PubMed  Google Scholar 

Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadi-Lari M. Prevalence, awareness, treatment and control of diabetes among iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys. BMC Public Health. 2022;22(1):1216.

Article  PubMed  PubMed Central  Google Scholar 

Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.

Article  PubMed  PubMed Central  Google Scholar 

Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL-D, Sacre JW, Karuranga S, et al. IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022;183:109118.

Article  PubMed  Google Scholar 

Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014;37(12):3172–9.

Article  PubMed  Google Scholar 

Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B et al. Protocol design for large–scale cross–sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9).

Djalalinia SAS, Ghasemi E, Yoosefi M, Rezaei N, Farzi Y et al. Protocol design for surveillance of risk factors of non–communicable diseases during the COVID-19 pandemic: an experience from Iran STEPS Survey 2021. Arch Iran Med. 2022.

(ADA) ADA. American Diabetes Association diabetes mellitus Diagnosis [Available from: https://diabetes.org/diabetes/a1c/diagnosis.

WHO. Global physical activity questionnaire (GPAQ) 2021 [Available from: https://www.who.int/publications/m/item/global-physical-activity-questionnaire.

Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20:1–9.

Article  Google Scholar 

WHO. NCD global monitoring framework [Available from: https://www.who.int/teams/ncds/surveillance/monitoring-capacity/gmf.

Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59:1396–9.

Article  CAS  PubMed  Google Scholar 

Au CPY, Raynes-Greenow CH, Turner RM, Carberry AE, Jeffery HE. Antenatal management of gestational diabetes mellitus can improve neonatal outcomes. Midwifery. 2016;34:66–71.

Article  PubMed  Google Scholar 

Tabatabaei-Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS ONE. 2021;16(3):e0241926.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Djalalinia S, Yoosefi M, Shahin S, Ghasemi E, Rezaei N, Ahmadi N, et al. The levels of BMI and patterns of obesity and overweight during the COVID-19 pandemic: experience from the Iran STEPs 2021 survey. Front Endocrinol. 2022;13:1043894.

Article  Google Scholar 

Khorrami Z, Yarahmadi S, Etemad K, Khodakarim S, Kameli ME, Hazaveh ARM. Urban-rural differences in the prevalence of self-reported diabetes and its risk factors: the WHO STEPS iranian noncommunicable disease risk factor surveillance in 2011. Iran J Med Sci. 2017;42(5):481.

PubMed  PubMed Central  Google Scholar 

Nejadghaderi SA, Ahmadi N, Rashidi M-M, Ghanbari A, Noori M, Abbasi-Kangevari M, et al. Physical activity pattern in Iran: findings from STEPS 2021. Front Public Health. 2023;10:1036219.

Article  PubMed  PubMed Central  Google Scholar 

Aung WP, Htet AS, Bjertness E, Stigum H, Chongsuvivatwong V, Kjøllesdal MKR. Urban–rural differences in the prevalence of diabetes mellitus among 25–74 year-old adults of the Yangon Region, Myanmar: two cross-sectional studies. BMJ open. 2018;8(3):e020406.

Article  PubMed  PubMed Central  Google Scholar 

Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab. 2015;19(6):744–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–27.

Article  PubMed  Google Scholar 

Aswathi V, Chowta MN, Achappa B, Madi D. Correlation of awareness of the disease with glycaemic control and diabetic complications among patients attending a tertiary care hospital. Clin Diabetol. 2019;8(3):143–53.

Article  Google Scholar 

Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet Global Health. 2018;6(11):e1196–e252.

Article  PubMed  PubMed Central  Google Scholar 

Akbarialiabad H, Rastegar A, Bastani B. How sanctions have impacted iranian healthcare sector: a brief review. Arch Iran Med. 2021;24(1):58–63.

Article  PubMed  Google Scholar 

Fattahi N, Azadnajafabad S, Mohammadi E, Aminorroaya A, Rezaei S, Ghasemi E et al. Geographical, gender and age inequalities in non-communicable diseases both at national and provincial levels in Iran. J Diabetes Metabolic Disorders. 2021:1–7.

Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: a modeling study. PLoS ONE. 2019;14(2):e0211622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirahmadizadeh A, Sharifi MH, Hassanzadeh J, Heiran A, Ardekani FM, Hadizadeh N, et al. The effect of COVID-19 pandemic on diabetes care indices in Southern Iran: an interrupted time series analysis. BMC Health Serv Res. 2023;23(1):1–9.

Article  Google Scholar 

Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: where we stand and where we are headed. Annals of Global Health. 2015;81(6):839–50.

Article  PubMed  Google Scholar 

Dehghani Firouzabadi M, Sheikhy A, Poopak A, Esteghamati A, Mechanick JI, Dehghani Firouzabadi F. Challenges to Lifestyle Medicine for type 2 diabetes in Iran: a synoptic review. Am J Lifestyle Med. 2023:15598276231167787.

Moradi G, Shokri A, Mohamadi-Bolbanabad A, Zareie B, Piroozi B. Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: a national survey in Iran. Heliyon. 2021;7(3).